Keyphrases
Visceral Leishmaniasis
100%
PA-824
50%
Arsenic in Drinking Water
50%
Oral Treatment
50%
R-enantiomer
50%
Antitubercular Agents
50%
Chronic Exposure
50%
Antimonial Drugs
50%
Pentostam
50%
Mouse Model
50%
Antimonial Resistance
33%
Arsenic Contamination
33%
Leishmania
27%
Leishmania Donovani
20%
Environmentally Relevant
16%
Meglumine Antimoniate
16%
Arsenic Exposure
16%
Parasite Resistance
16%
Pentavalent
16%
Glucantime
16%
Bihar
16%
Trivalent Arsenic
16%
Arsenic Accumulation
16%
Liver Biopsy
16%
Drug-resistant Parasites
16%
Antimony
16%
India
16%
Sodium Stibogluconate
16%
Metalloids
16%
Inappropriate Treatment
16%
Cross-resistance
16%
Exposure Level
16%
Peritoneal Macrophages
16%
Human Liver
16%
Culture in Vitro
16%
Indian Subcontinent
16%
Infected Mice
16%
Parasitic Diseases
16%
Arsenic
16%
Drinking Water
16%
Fexinidazole
10%
Mycobacterium Tuberculosis (M. tb)
10%
Phase II Clinical Trial
7%
Nitroreductase
7%
Pharmacology, Toxicology and Pharmaceutical Science
Visceral Leishmaniasis
100%
Mouse Model
50%
Long Term Exposure
50%
Antimonial
50%
Leishmania
40%
Sodium Stibogluconate
40%
Fexinidazole
30%
Meglumine Antimonate
20%
Clinical Trial
20%
Nitroreductase
20%
Leishmania donovani
20%
Mycobacterium Tuberculosis
10%
Antibacterial Activity
10%
Nifurtimox
10%
Prodrug
10%
Combination Therapy
10%
Combination Drug
10%
Cross-Resistance
10%
Parasitosis
10%
Metalloid
10%
Medicine and Dentistry
Long Term Exposure
50%
Visceral Leishmaniasis
50%
Sodium Stibogluconate
50%
In Vitro
25%
Meglumine Antimonate
25%
Parasitology
25%
Leishmania
12%
Macrophage
12%
Cross Resistance
12%
Leishmania donovani
12%
Metalloid
12%
Parasitic Disease
12%
Liver Biopsy
12%